Girao Tiago Insider Trades

Insider Trading History

Track insider trading activity for Girao Tiago. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Immunovant
Immunovant IMVT
Chief Financial Officer
Holding Value $7.71M 247,596 shares
Last Trade
Apr 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$763k 25,760 shares
$29.62
$31.15
Immunovant
Immunovant IMVT
Chief Financial Officer
Holding Value $8.52M 273,356 shares
Last Trade
Apr 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.91M 158,970 shares
$24.61
$31.15
Immunovant
Immunovant IMVT
Chief Financial Officer
Holding Value $9.14M 293,505 shares
Last Trade
May 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.67M 293,505 shares
$15.90
$31.15
Landos Biopharma
Landos Biopharma LABP
Director
Holding Value $0 0 shares
Last Trade
May 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$124k 5,400 shares
$22.93
$22.93
Landos Biopharma
Landos Biopharma LABP
Director
Holding Value $413k 18,000 shares
Last Trade
May 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$592k 18,000 shares
$32.90
$22.93
Landos Biopharma
Landos Biopharma LABP
Director
Holding Value $413k 18,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.65M 18,000 shares
$91.45
$22.93
Landos Biopharma
Landos Biopharma LABP
Director
Holding Value $413k 18,000 shares
Last Trade
May 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.16M 18,000 shares
$64.34
$22.93
Landos Biopharma
Landos Biopharma LABP
Director
Holding Value $825k 36,000 shares
Last Trade
Apr 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.6M 36,000 shares
$1,016.00
$22.93
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jul 25, 2018 Sale (In The Money)Reported as In The Money on SEC Form 4.
$0.72 1 shares
$0.72
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $5.69k 1,050 shares
Last Trade
Jul 25, 2018 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$757 1,051 shares
$0.72
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $9.76k 1,800 shares
Last Trade
Nov 28, 2017 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$128M 1,801 shares
$71,250.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 28, 2017 Sale (In The Money)Reported as In The Money on SEC Form 4.
$71.3k 1 shares
$71,250.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $228k 42,000 shares
Last Trade
Mar 08, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.2B 42,000 shares
$290,625.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $169k 31,100 shares
Last Trade
Mar 08, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.04B 31,100 shares
$290,625.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $76.3k 14,084 shares
Last Trade
Jun 15, 2016 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$3.44B 8,500 shares
$405,000.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 15, 2016 Sale (In The Money)Reported as In The Money on SEC Form 4.
$2.3B 5,667 shares
$405,000.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $684k 126,250 shares
Last Trade
Jan 28, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.8B 35,250 shares
$562,500.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $668k 123,250 shares
Last Trade
Jan 28, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.8B 35,250 shares
$562,500.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $3.36M 619,830 shares
Last Trade
Jan 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$187B 349,830 shares
$534,375.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
VP & Chief Financial Officer
Holding Value $477k 88,000 shares
Last Trade
Aug 18, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$28.1B 25,000 shares
$1,125,000.00
$5.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up